Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The angiotensin converting enzyme inhibitor drugs are now standard therapy for patients with diabetic nephropathy. The hypothesis of this study is that adding a diuretic agent (furosemide) will decrease the urine protein, which is a sign of disease, more than an angiotensin converting enzyme inhibitor alone.
Sex
Ages
Volunteers
Inclusion criteria
proteinuria greater than 1 gram/day serum creatinine < 2.6 for men, < 2.0 for women
Exclusion criteria
blood pressure which cannot be controlled without a diuretic renal diseases other than diabetic nephropathy other disease which would alter renal function during 6 months
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal